跳至主要内容
临床试验/ISRCTN07034656
ISRCTN07034656已完成未知

Biochemical Efficacy and Safety Trial of vitamin D (BEST-D): a dose-finding trial assessing biochemical and vascular effects of high dose vitamin D

niversity of Oxford (UK)0 个研究点目标入组 300 人开始时间: 2012年4月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age = 65 years
  • 2. Living in the community and ambulatory

排除标准

  • 1. Nursing home residents
  • 2. Regular use of vitamin D supplements with >400 IU (10 µg) vitamin D daily
  • 3. Use of alendronate, risedronate, zoledronic acid, parathyroid hormone, or calcitonin
  • 4. Medically diagnosed dementia
  • 5. History of hypercalcaemia, hyperparathyroidism, lymphoma, sarcoidosis, active tuberculosis
  • 6. History of renal calculus
  • 7. Known to be poorly compliant with clinic visits or with taking medication
  • 8. Recent history of alcohol or substance misuse or abuse
  • 9. Medical history that might limit the ability of the subject to take the study treatment for the duration of the study (e.g. terminal illness)
  • 10. Regular prescribed calcium supplements

研究者

发起方
niversity of Oxford (UK)

相似试验